The goal of this project is to demonstrate that incorporating biological indices into the optimization of intensity-modulation can result in a significant improvement in 3D conformal treatment plans compared to corresponding plans which are optimized based purely on dose and simple dose-volume criteria. Intensity modulation provides a greatly increased control over dose distributions. Such control can be maximally exploited to achieve the desired results using sophisticated optimization techniques. However, it is important that the objectives of optimization be specified in a clinically relevant manner in order that the results be clinically optimum. Dose-based, dose-volume based and biology-based intensity modulation optimization techniques will be applied to groups of prostate, brain and lung 3D conformal treatment plans. These plans will be compared among themselves as well as with the best non-intensity- modulated treatment plans designed by a planner. The results will be used to evaluate the relative strengths and weaknesses of various techniques and to explore the reasons for the differences between them. The intensity-modulation optimization methodology, a rudimentary version of which has been implemented in the preliminary work, will be refined. The impact of the models (serial, parallel or phenomenological) chosen to compute biological indices and their parameters on the proficiency and efficiency of the optimization process will be examined. For each class of radiotherapy problems, the parameters of the models will be adjusted to produce results that are consistent with the judgment of physicians and planners as well as with published data. Methods will be developed to accurately account for the non-local nature of radiation dose deposition in the design of optimum intensity distributions. The importance of accurate accounting of scatter on the optimality of intensity-modulated plans will be investigated. For each site and stage, the optimum number of beams for intensity-modulated treatments will be determined. The value of including non-coplanar beams will be explored. Using alpha-beta models, the potential radiobiological consequences of the various fractionation schemes involving intensity- modulated treatments will be compared. Mathematical aspects of intensity-modulation optimization methods, including multiple minima and methods to accelerate the optimization process, will be investigated. It is expected that the outcome of the proposed investigations will permit the development of intensity-modulated treatment plans in which dose to the tumor can be escalated significantly for the same or lower probability of normal tissue damage, potentially improving local control and hence, survival.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074043-03
Application #
2769934
Study Section
Radiation Study Section (RAD)
Program Officer
Stone, Helen B
Project Start
1996-09-01
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
2000-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Mohan, Radhe; Grosshans, David (2017) Proton therapy - Present and future. Adv Drug Deliv Rev 109:26-44
Zhu, Zhengfei; Liu, Wei; Gillin, Michael et al. (2014) Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial. Radiat Oncol 9:108
Chang, Joe Y; Li, Heng; Zhu, X Ronald et al. (2014) Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys 90:809-18
Mohan, Radhe; Mahajan, Anita; Minsky, Bruce D (2013) New strategies in radiation therapy: exploiting the full potential of protons. Clin Cancer Res 19:6338-43
Koay, Eugene J; Lege, David; Mohan, Radhe et al. (2012) Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84:1093-100
Chang, Joe Y; Komaki, Ritsuko; Wen, Hong Y et al. (2011) Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 80:1350-7
Register, Steven P; Zhang, Xiaodong; Mohan, Radhe et al. (2011) Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 80:1015-22
Zhang, Xiaodong; Li, Yupeng; Pan, Xiaoning et al. (2010) Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung canc Int J Radiat Oncol Biol Phys 77:357-66
Chang, Joe Y; Cox, James D (2010) Improving radiation conformality in the treatment of non-small cell lung cancer. Semin Radiat Oncol 20:171-7
Reed, Valerie K; Woodward, Wendy A; Zhang, Lifei et al. (2009) Automatic segmentation of whole breast using atlas approach and deformable image registration. Int J Radiat Oncol Biol Phys 73:1493-500

Showing the most recent 10 out of 68 publications